Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Tolterodine for overactive bladder

Article Abstract:

Tolterodine has fewer side effects than other drugs used to treat an overactive bladder, but it may not be as effective. An overactive bladder leads to frequent urination and urinary incontinence. Most drugs used to treat overactive bladder belong to a class of drugs called anti-muscarinic drugs because they block muscarinic cell receptors. Sold under the trade name Detrol, tolterodine also blocks these receptors . It is less likely to cause the usual side effects of these drugs, including dry mouth, intellectual impairment and heart problems.

Publisher: Medical Letter, Inc.
Publication Name: Medical Letter on Drugs and Therapeutics
Subject: Health
ISSN: 0025-732X
Year: 1998
Detrol (Medication)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: A randomized controlled trial

Article Abstract:

A randomized controlled trial is used to evaluate the efficacy and safety of tolterodine extended release (ER), tamsulosin, or both in men who met research criteria for both overactive bladder and benign prostatic hyperplasia. The results have suggested that treatment with tolterodine ER plus tamsulosin for 12 weeks is beneficial for men with moderate to severe lower urinary tract symptoms including overactive bladder.

Author: Roehrborn, Claus G., Kaplan, Steven A., Rovner, Eric S., Carlsson, Martin
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2006
Dosage and administration, Urinary tract infections, Tolterodine tartrate, Clinical report, Tamsulosin hydrochloride, Tamsulosin

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Detrol LA and Ditropan XL for overactive bladder

Article Abstract:

Detrol LA and Ditropan XL are extended-release forms of two drugs used to treat an overactive bladder, the most common cause of urinary incontinence in the elderly. These two drugs are being advertised directly to the public but the ads may overestimate their effectiveness.

Publisher: Medical Letter, Inc.
Publication Name: Medical Letter on Drugs and Therapeutics
Subject: Health
ISSN: 0025-732X
Year: 2001
Product information, Pharmacia Inc., Detrol LA (Medication), Ditropan (Medication)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Evaluation, Product/Service Evaluation, Urinary incontinence, Drug therapy
Similar abstracts:
  • Abstracts: Information for patients having bladder augmentation. A weight of her shoulders
  • Abstracts: A national model for participative management and policy development. Quality measures essential to the transformation of the veterans health administration: Implications for nurses as co-creators of change
  • Abstracts: Guidelines for managing domestic abuse when male and female partners are patients of the same physician. Facing the future
  • Abstracts: Shared care provides postoperative help. Childhood obesity: its incidence, consequences and prevention
  • Abstracts: International variability in ages at menarche, first livebirth, and menopause. Lifetimes exposure to environmental tobacco smoke among urban women: differences by socioeconomic class
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.